1. New research facilities for studying children's cancer

    New facilities have been opened for the children's oncology laboratory of the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital to celebrate 20 years of research. These laboratories are unique in their exclusive dedication to pediatric tumors and have over 50 researchers who focus on the study of more than ten developmental tumors.

  2. The IRSJD joins the XarSMART network to promote the transfer of medical technology in Catalonia.

    The Institut de Recerca Sant Joan de Déu (IRSJD) participates in XarSMART, a project that aims to promote the generation of medical technologies and new companies in Catalonia in the field of life sciences and health.

  3. Benefits of listening to music during pregnancy on baby's brain capacity for language sound encoding

    The study, led by Dr. Carles Escera · Institut de Recerca Sant Joan de Déu, shows that when pregnant women sing to their baby or listen to music with speakers every day during gestation, babies are born with a better ability for neuronal encoding of language sounds.

  4. Researchers generate a stem cell-based model to study an ultra-rare disease that causes childhood parkinsonism

    Researchers from the Institut de Recerca Sant Joan de Déu (IRSJD), the Bellvitge Biomedical Research Institute (IDIBELL), Sant Pau Research Institute (IIB Sant Pau) and the UB generated the first model of this disease that reproduce patients' characteristics and response to treatment.

  5. IRSJD researchers have discovered an intergenerational inheritance mechanism in mouse models of childhood obesity

    A study led by Dr. Josep Jiménez-Chillaron, a researcher at the Institut de Recerca Sant Joan de Déu and the University of Barcelona, suggests that hepatic steatosis could be intergenerationally inherited through paternal germ line microRNAs. Hepatic steatosis is a condition that is associated with childhood obesity. The results of this study have been published in the scientific journal Nutrients.

  6. An early diagnosis and some diet changes can decrease the risk of severe symptoms in children with BCKDK metabolic deficiency

    The research, under the leadership of Dr. Àngels García-Cazorla at the Institut de Recerca Sant Joan de Déu, has demonstrated that early identification of this disease is possible through the standard neonatal screening test, also known as the heel prick test.

  7. Experts in nanomedicine come together to tackle rare diseases

    The fourth edition of the "Nanorare Disease Day" event was held on February 28th, in collaboration between the Institut de Recerca Sant Joan de Déu de Barcelona and NanomedSpain, on World Rare Disease Day. 

  8. Researchers at IRSJD develop a method to predict the efficacy of a potent nanomedicine in a severe childhood cancer

    Researchers at IRSJD have developed a method that predicts the anticancer efficacy of nab-paclitaxel, a well-known nanomedicine, in mouse models, for treatment of Ewing sarcoma, a severe cancer affecting the bones and soft tissue of children and adolescents.

  9. Dr. Joan Comella, new director of the Institut de Recerca Sant Joan de Déu

    The Governing Council​ of the Institute de Recerca Sant Joan de Déu (IRSJD) has appointed Dr. Joan Comella as director of the Institute. We thank Dr. Francesc Palau for his years of dedication to the management.